Endo Int'l (NASDAQ: ENDP) reported Q1 EPS of $1.08, $0.04 better than the analyst estimate of $1.04. Revenue for the quarter came in at $963.5 million versus the consensus estimate of $955.91 million.

GUIDANCE:

Endo Int'l sees FY2016 EPS of $4.50-$4.80, versus the consensus of $5.69. Endo Int'l sees FY2016 revenue of $3.87-4.03 million, versus the consensus of $4.29 million.

For earnings history and earnings-related data on Endo Int'l (ENDP) click here.

Earnings Guidance Hot Earnings Hot Guidance

RBC Capital Downgrades Endo International plc (ENDP) to Sector PerformMay 6, 2016 6:47 AM Guggenheim Cuts Price Target as Endo Int'l (ENDP) Cuts EPS Guidance May 6, 2016 6:43 AM Piper Jaffray Downgrades Endo International plc (ENDP) to NeutralMay 6, 2016 6:29 AM Mizuho Securities Downgrades Endo International plc (ENDP) to Underperform; Stock is 'Toxic'May 6, 2016 6:26 AM Leerink Partners Downgrades Endo International plc (ENDP) to Market PerformMay 6, 2016 6:24 AM Endo Reports First Quarter 2016 Financial ResultsMay 5, 2016 4:06 PM